SEARCH

SEARCH BY CITATION

Keywords:

  • type 1 diabetes;
  • autoimmunity;
  • prevention;
  • vitamin D;
  • pilot randomized controlled trial

Abstract: Recent epidemiologic, immunologic, and NOD mouse studies suggest that intervention in the vitamin D system may be a successful method to prevent type 1 diabetes. Newborns at increased HLA-associated risk are randomized to receive either 400 or 2000 IU vitamin D3 by 1 month of age. We show that recruitment of babies from the general population for identification of HLA-associated risk status followed by enrollment to a randomized controlled prevention trial is feasible in Canada.